Related Experiment Video
Updated: Mar 26, 2026
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
The further characterization of the peptide specifically binding to gastric cancer
Juanjuan Han1, Xiaojie Gao1, Wei Duan2
1Co-Innovation Center for Qinba Region's Sustainable Development, Shaanxi Normal University, Xi'an, Shaanxi 710062, China.
Abstract:
Targeting peptide has been considered to be useful as a small molecule probe leading to multifunctional properties for both imaging detection and targeting therapy. Thus, the identification of novel targets is urgently needed to develop innovative agents to effectively control gastric cancer metastasis and progression. Previously, we reported a novel 12-mer peptide, GP-5 (IHKDKNAPSLVP), binding to gastric carcinoma (GC) cells specifically and sensitively, and it was screened by using a phage displayed peptide library and primarily analyzed. In this study, it was further identified via fluorescence microscopy, flow cytometry, tissue chip and other methods. Our results indicated that the peptide GP-5 presents a particularly high affinity and specificity to GC cells and tissues, whereas only background detection occurred with other control cancer cells, cancer tissues or normal tissues. Taken together, all results support that the peptide GP-5 is a potential candidate to be developed as a useful molecule fragment for the imaging detection and targeting therapy of GC.
Insights
Researchers identified a novel peptide, GP-5, that specifically targets gastric carcinoma (GC) cells. This peptide shows potential for developing new imaging and therapeutic agents for gastric cancer metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Targeting peptides are crucial for developing multifunctional small molecule probes.
- Novel targets are needed to combat gastric cancer (GC) metastasis and progression.
- Previous work identified the 12-mer peptide GP-5 (IHKDKNAPSLVP) that binds to GC cells.
Purpose of the Study:
- To further identify and validate the specificity and affinity of the peptide GP-5 for gastric carcinoma cells.
- To assess the potential of GP-5 as a diagnostic and therapeutic agent for GC.
Main Methods:
- Phage displayed peptide library screening.
- Fluorescence microscopy.
- Flow cytometry.
- Tissue chip analysis.
Main Results:
- Peptide GP-5 demonstrated high affinity and specificity for gastric carcinoma cells and tissues.
- Background detection was observed in control cancer cells, cancer tissues, and normal tissues.
- GP-5 showed selective binding to GC targets.
Conclusions:
- The peptide GP-5 is a promising candidate for developing molecular fragments for GC imaging detection.
- GP-5 holds potential for targeted therapy in gastric cancer.
- Further development of GP-5 could lead to innovative agents for controlling GC progression.
More Related Videos
Related Concept Videos
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
01:27Peptic Ulcer